Program for Health Promotion to Improve Therapeutic Compliance in Hypertensive Patiente (PHPTCHP)
Primary Purpose
Hypertension
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Program Health Education
Sponsored by

About this trial
This is an interventional health services research trial for Hypertension focused on measuring Hypertension, Nursing, Therapeutic compliance, Quality of life, Health education
Eligibility Criteria
Inclusion criteria:
- Hypertensive patients under treatment regimen;
- Pressure levels greater than or equal to 90 mmHg diastolic blood pressure (DBP), and
- Pressure level greater than or equal to 140 mmHg systolic blood pressure (SBP)
- Age limit between 25 to 75 years, for both female and male.
Exclusion Criteria:
- Diabetes patients
Sites / Locations
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Experimental
Arm Label
Group A who underwent to an inter-relational strategy
Group B who underwent group orientation by the nurse
Arm Description
Group A who underwent to a health educational orientation program (inter-relational strategy)
Outcomes
Primary Outcome Measures
measure blood pressure arterial
At the first nurse interview (day 0: randomization) three consecutive measurements of BP were taken after the patient had rested for 5 min in the supine position.Ambulatory BP monitoring was recorded at 15 and 180 days of follow-up for 24 h with a noninvasive ABPM (Space Labs 90207 monitor; Space Labs, Redmond, WA) with an appropriate-sized cuff. The monitor was placed on the nondominant arm and was set to take BP readings every 10 min during the day and every 20 min at night
Secondary Outcome Measures
QoL questionnaire (WHOQoL-Brief)
At the first nurse interview (day 0: randomization), a questionnaire was used to obtain information related to general data, habits, history of disease, other risk factors for cardiovascular disease, and prescribed medications. This questionnaire was used only to characterize the adherence behavior and the risk factors at the beginning the study, but was not used to evaluate modifications of behavior during the study.
Full Information
NCT ID
NCT02036814
First Posted
October 11, 2013
Last Updated
January 14, 2014
Sponsor
University of Sao Paulo General Hospital
Collaborators
InCor Heart Institute
1. Study Identification
Unique Protocol Identification Number
NCT02036814
Brief Title
Program for Health Promotion to Improve Therapeutic Compliance in Hypertensive Patiente
Acronym
PHPTCHP
Official Title
A PROGRAM OF HEALTH EDUCATION PROMOTION BY NURSING CAN IMPROVE BLOOD PRESSURE CONTROL AND QUALITY OF LIFE IN HYPERTENSIVE PATIENTS?
Study Type
Interventional
2. Study Status
Record Verification Date
January 2014
Overall Recruitment Status
Completed
Study Start Date
March 2007 (undefined)
Primary Completion Date
March 2008 (Actual)
Study Completion Date
February 2011 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of Sao Paulo General Hospital
Collaborators
InCor Heart Institute
4. Oversight
Data Monitoring Committee
Yes
5. Study Description
Brief Summary
The aim was to test if interpersonal relationships group strategies provided by nursing can promote an additional benefit on blood pressure (BP) control and quality of life (QoL) in hypertensive patients. Methods: 21 treated patients were randomized into two groups: Group A 10 patients (8 women), underwent to a health educational orientation program (inter-relational strategy), with group meetings every 15 days during 4 months(8 meetings). Group B 11 patients (7 women), who underwent group orientation by the nurse every 40 days during 4 months (3 meetings). Both groups received the same content guidelines (healthy lifestyle and prevention of risk factors). The patients had 2 visits by nurses at baseline (15 days) and at the final study (120 days). BP was measured by auscultatory method and QoL questionnaire (WHOQoL-Brief)was applied. The dispensing and pill counts were done every 30 days. Ambulatory blood pressure monitoring (ABPM) was performed at baseline and after 120 days.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Hypertension
Keywords
Hypertension, Nursing, Therapeutic compliance, Quality of life, Health education
7. Study Design
Primary Purpose
Health Services Research
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
21 (Actual)
8. Arms, Groups, and Interventions
Arm Title
Group A who underwent to an inter-relational strategy
Arm Type
Experimental
Arm Description
Group A who underwent to a health educational orientation program (inter-relational strategy)
Arm Title
Group B who underwent group orientation by the nurse
Arm Type
Experimental
Intervention Type
Behavioral
Intervention Name(s)
Program Health Education
Primary Outcome Measure Information:
Title
measure blood pressure arterial
Description
At the first nurse interview (day 0: randomization) three consecutive measurements of BP were taken after the patient had rested for 5 min in the supine position.Ambulatory BP monitoring was recorded at 15 and 180 days of follow-up for 24 h with a noninvasive ABPM (Space Labs 90207 monitor; Space Labs, Redmond, WA) with an appropriate-sized cuff. The monitor was placed on the nondominant arm and was set to take BP readings every 10 min during the day and every 20 min at night
Time Frame
4 months
Secondary Outcome Measure Information:
Title
QoL questionnaire (WHOQoL-Brief)
Description
At the first nurse interview (day 0: randomization), a questionnaire was used to obtain information related to general data, habits, history of disease, other risk factors for cardiovascular disease, and prescribed medications. This questionnaire was used only to characterize the adherence behavior and the risk factors at the beginning the study, but was not used to evaluate modifications of behavior during the study.
Time Frame
4 months
10. Eligibility
Sex
All
Minimum Age & Unit of Time
25 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion criteria:
Hypertensive patients under treatment regimen;
Pressure levels greater than or equal to 90 mmHg diastolic blood pressure (DBP), and
Pressure level greater than or equal to 140 mmHg systolic blood pressure (SBP)
Age limit between 25 to 75 years, for both female and male.
Exclusion Criteria:
Diabetes patients
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Heno Ferreira Lopes, PhD
Organizational Affiliation
Heart Institute of Medicine School of University of São Paulo
Official's Role
Study Chair
12. IPD Sharing Statement
Learn more about this trial
Program for Health Promotion to Improve Therapeutic Compliance in Hypertensive Patiente
We'll reach out to this number within 24 hrs